Carolyn Yarina, Co-Founder and Chief Executive Officer
Carolynmanages Sisu’s strategy, business development, finances, and fundraising. Carolyn has raised over $1M of investment from investors including Steve Case, Camden Partners and Keiretsu Capital. She has received numerous awards including first place in South by Southwest Eco’s Social Impact Category, won Baltimore’s Rise of the Rest with Steve Case, and was a 2016 Tedx Mid-Atlantic speaker. Prior to Sisu, Carolyn founded a medical device non-profit working with rural mobile clinics in India. She raised over $100k in cash and in-kind services and was featured in Entrepreneur Magazine and Business Insider. While getting her Chemical Engineering Degree at the University of Michigan, Carolyn was named Entrepreneur of the Year for her first company.
Gillian manages Sisu’s products and technical strategy. She is the primary inventor of Hemafuse and has directed Hemafuse’s development from an idea to fully manufactured, injection-molded device. Gillian previously founded a medical device design firm for Ghana. She has been published in the International Journal of Gynecology and Obstetrics, has presented at the Midwest Biomedical Engineering Career Conference and Appropriate Healthcare Technologies for Developing Countries Seminar in London, and was named Baltimore’s 2016 Technologist of the Year at Baltimore’s 4th Annual Innovation awards.
Katie Kirsch, Chief Marketing Officer and Co-Founder
Katiemanages Sisu’s in-Africa operations, relationships and marketing. Katie setup and coordinated Hemafuse’s clinical pilot in Ethiopia, incorporated Sisu’s subsidiary in Ghana, and inspired advocates and champions across Sub-Saharan Africa. She has gathered 5 letters of support from hospitals with over $2M of purchasing potential for Hemafuse and letters of engagement from distributors in 3 regions of Africa. Katie lays the groundwork for Sisu’s market launch in Africa. Prior to Sisu, Katie coordinated public-private partnerships across Sub-Saharan Africa with embassies, universities and NGOs. Katie is a former Fulbright fellow in Rwanda, a panelist for the Gates Foundation annual conference, and a presenter at Nigeria’s Bloodless Medicine and Surgery Conference.
Sajju Jain, Chief Operating Officer and Advisory Board Member
Sajju manages Sisu’s operations, supply chain, and project management. Sajju was formerly on Sisu’s advisory board and transitioned into an operations role in late 2016. Sajju Jain is a serial entrepreneur, mentor, and teacher with over twenty years of senior management experience in industries such as computers, polymers, outsourcing services, management consulting, renewal energy, and healthcare among others.
In 2008 he found his calling in the world of for-profit social enterprise and has dedicated the last eight years to galvanizing innovative technologies to address societal challenges such as eradication of kerosene lanterns (Dlight Design Inc.), infant mortality (Embrace Technologies Inc.), and job creation through entrepreneurship education & mentorship (Standard Skills Development Pvt. Ltd.). His ventures have been featured on BBC, CNBC, CNN, ABC, Forbes, Wall Street Journal, and many other media outlets across the world. He is an alumnus of the Harvard Business School (ExecEd) and has an MBA from the University of Iowa.
Mihir develops Sisu's products, testing, and purchase activities. While earning a Master’s in Electrical Engineering at the University of Michigan, he worked on developing several biomedical devices, including a device to convert the eye’s motions into electrical energy, a joystick that non-invasively measured chimpanzee’s vital signs and a hybrid infant incubator/kangaroo-care pouch. He was named as the University of Michigan’s Quiet Influencer of the Year in 2015.
Jack serves as Quality Specialist for Sisu Global Health. Jack is an experienced medical device executive with significant prior work leading companies in efforts to deliver novel technology and positively impact patient care. In his most recent endeavor, Jack directed 6 product development projects from concept to delivery. These products are now available in the United States, the European Union, and Canada. His team successfully navigated FDA reviews, CE Mark reviews, FDA inspections, and ISO 13485 Notified Body audits – among other activities. Jack has worked with diverse product types, ranging in specialty (e.g., IR, GI, ORTH), use (therapeutic/diagnostic), and other characteristics (e.g., electrical, single-use vs. reusable, sterile/nonsterile, software).
Additionally, Jack has focused his career on assisting start-up companies navigate the complex environment surrounding medical devices. Jack also hopes to foster economic growth in Maryland through the development of novel technologies. To this end, he studied innovation and entrepreneurship at Johns Hopkins University, earning two masters degrees (in business and public health). Jack previously served as Managing Director, Innovative Healthcare Products, at Becker & Associates Consulting, a boutique consulting firm located in Washington, D.C. Jack holds a B.S.E. in Bioengineering from the Univ. of Pennsylvania, as well as MBA and MPH degrees from Johns Hopkins University.
Nao serves as a grant writer and consultant for Sisu Global Health. She brings over 10 years’ experience in academic translational research in neuroscience and psychiatry, during which she was supported by highly competitive grants, including from the NIH, Brain & Behavior Research Foundation, and TEDCO. She has 13 peer-reviewed publications, and has extensive experience in editing language and scientific content for non-native English speakers. Her passion is for ensuring the applicability of science and technology at the interface of science, clinical applications, and business, and has established a wide network in the local entrepreneurial community. She has completed undergraduate degrees in Brain and Cognitive Sciences and Music from Massachusetts Institute of Technology, a PhD in Neurobiology from Yale University, and a postdoctoral fellowship in the Molecular Psychiatry Program at Johns Hopkins University.